|
Net earnings (loss)
|
|
—
|
—
|
—
|
($34.2m)
|
($125.3m)
|
($31.3m)
|
($23.3m)
|
|
Net Income
|
|
—
|
—
|
—
|
($34.2m)
|
($125.3m)
|
($31.3m)
|
($23.4m)
|
|
Net Income From Continuing Operations
|
|
—
|
—
|
—
|
($34.2m)
|
($125.3m)
|
($31.3m)
|
($23.3m)
|
|
Depreciation and amortization
|
|
—
|
$93k
|
$273k
|
$71.7m
|
$71.0m
|
$62.8m
|
$75.6m
|
|
Depreciation - cost of sales
|
|
—
|
$479k
|
$826k
|
$875k
|
—
|
—
|
—
|
|
Depreciation Amortization Depletion
|
|
—
|
—
|
—
|
$71.7m
|
$71.0m
|
$62.8m
|
$75.6m
|
|
Deferred income tax expense (benefit)
|
|
—
|
—
|
—
|
($10.4m)
|
($7.9m)
|
($9.3m)
|
($2.4m)
|
|
Deferred income tax recovery
|
|
—
|
$0
|
($31k)
|
($152k)
|
—
|
—
|
—
|
|
Deferred Income Tax
|
|
—
|
—
|
—
|
($10.4m)
|
($7.9m)
|
($9.3m)
|
($2.4m)
|
|
Deferred Tax
|
|
—
|
—
|
—
|
($10.4m)
|
($7.9m)
|
($9.3m)
|
($2.4m)
|
|
Impairment expense
|
|
—
|
—
|
—
|
—
|
—
|
—
|
$30.1m
|
|
Share-based payments
|
|
—
|
$5.3m
|
$891k
|
$139k
|
—
|
—
|
—
|
|
Impairment of goodwill
|
|
—
|
$0
|
$0
|
$1.7m
|
—
|
—
|
—
|
|
Asset Impairment Charge
|
|
—
|
—
|
—
|
$4.8m
|
$0
|
$0
|
$30.1m
|
|
(Gains) losses on dispositions, net
|
|
—
|
—
|
—
|
($20.1m)
|
($2.3m)
|
—
|
—
|
|
Cash receipts from returns on equity method investments
|
|
—
|
—
|
—
|
$21.7m
|
$22.4m
|
$21.6m
|
$21.1m
|
|
Investments in equity method affiliates and equity securities
|
|
—
|
—
|
—
|
($5.3m)
|
($125k)
|
($334k)
|
—
|
|
Interest expense
|
|
—
|
$390k
|
$277k
|
$344k
|
—
|
—
|
—
|
|
Earnings (Loss)es From Equity Investments
|
|
—
|
—
|
—
|
($7.2m)
|
($4.5m)
|
($8.9m)
|
($8.3m)
|
|
Stock-based compensation
|
|
—
|
—
|
—
|
$12.2m
|
$13.2m
|
$16.5m
|
$15.6m
|
|
Share of (earnings) losses of affiliates, net
|
|
—
|
—
|
—
|
($28.9m)
|
($27.0m)
|
($30.5m)
|
($29.4m)
|
|
Realized and unrealized (gains) losses on intergroup interests, net
|
|
—
|
—
|
—
|
$35.2m
|
$83.2m
|
—
|
—
|
|
Realized and unrealized (gains) losses on financial instruments, net
|
|
—
|
—
|
—
|
($13.1m)
|
($2.3m)
|
($3.4m)
|
$1.0m
|
|
Other charges (credits), net
|
|
—
|
—
|
—
|
$2.3m
|
$1.2m
|
$1.9m
|
$6.5m
|
|
Current and other assets
|
|
—
|
—
|
—
|
$9.9m
|
($42.8m)
|
($15.8m)
|
($57.0m)
|
|
Payables and other liabilities
|
|
—
|
—
|
—
|
$3.4m
|
$13.1m
|
($1.7m)
|
($14.9m)
|
|
Capital expended for property and equipment
|
|
—
|
($1.8m)
|
($581k)
|
($625k)
|
($69.0m)
|
($86.0m)
|
($51.3m)
|
|
Acquisition of real estate assets
|
|
—
|
—
|
—
|
($17.7m)
|
($69.0m)
|
($86.0m)
|
($93.7m)
|
|
Borrowings of debt
|
|
—
|
—
|
—
|
$154.8m
|
$83.0m
|
$144.9m
|
$158.2m
|
|
Proceeds (disbursements) from exercise of stock options and other stock issuances
|
|
—
|
—
|
—
|
—
|
($689k)
|
$6.4m
|
$9.1m
|
|
Net loss and comprehensive loss for the year
|
|
—
|
($7.6m)
|
($2.7m)
|
($4.3m)
|
—
|
—
|
—
|
|
Services paid in shares
|
|
—
|
$132k
|
$0
|
$0
|
—
|
—
|
—
|
|
Interest income
|
|
—
|
($8k)
|
$0
|
$0
|
—
|
—
|
—
|
|
Loss on disposal of capital assets
|
|
—
|
$0
|
$150k
|
$0
|
—
|
—
|
—
|
|
Provision for expected credit losses
|
|
—
|
$0
|
$134k
|
$0
|
—
|
—
|
—
|
|
Accretion
|
|
—
|
$58k
|
$0
|
$0
|
—
|
—
|
—
|
|
Gain on settlement of accounts payable
|
|
—
|
$0
|
($53k)
|
($21k)
|
—
|
—
|
—
|
|
Loss on termination of license agreement
|
|
—
|
$0
|
$0
|
$1.5m
|
—
|
—
|
—
|
|
Realized loss on marketable securities
|
|
—
|
$2k
|
$0
|
$0
|
—
|
—
|
—
|
|
Amounts receivable
|
|
—
|
($669k)
|
($345k)
|
($3.6m)
|
—
|
—
|
—
|
|
Prepaid expenses and deposits
|
|
—
|
$950
|
($99k)
|
($264k)
|
—
|
—
|
—
|
|
Inventory
|
|
—
|
($1.4m)
|
($407k)
|
($2.2m)
|
—
|
—
|
—
|
|
Accounts payable and accrued liabilities
|
|
—
|
$419k
|
$82k
|
$6.5m
|
—
|
—
|
—
|
|
Deferred revenue
|
|
—
|
$0
|
$0
|
$276k
|
—
|
—
|
—
|
|
Cash provided by (used in) operating activities
|
|
—
|
($2.8m)
|
($1.1m)
|
$1.3m
|
$1.6m
|
$16.6m
|
$25.2m
|
|
Consideration paid on acquisition of Perceive MD
|
|
—
|
$0
|
($10k)
|
$0
|
—
|
—
|
—
|
|
Cash received from the acquisition of Perceive MD
|
|
—
|
$0
|
$26k
|
$0
|
—
|
—
|
—
|
|
Cash received from the acquisition of AH BrandCo
|
|
—
|
$0
|
$302k
|
$0
|
—
|
—
|
—
|
|
Long term excise stamp deposits
|
|
—
|
$0
|
$0
|
($402k)
|
—
|
—
|
—
|
|
Purchases of property and equipment
|
|
—
|
($1.8m)
|
($581k)
|
($625k)
|
$69.0m
|
$86.0m
|
$51.3m
|
|
Cash used in investing activities
|
|
—
|
($1.8m)
|
($263k)
|
($1.0m)
|
—
|
—
|
—
|
|
Proceeds on private placement of units, net of share issue costs
|
|
—
|
$3.5m
|
$135k
|
$0
|
—
|
—
|
—
|
|
Proceeds from warrants exercise
|
|
—
|
$77k
|
$0
|
$0
|
—
|
—
|
—
|
|
Proceeds from mortgage renegotiation, net of transaction costs
|
|
—
|
$0
|
$993k
|
$0
|
—
|
—
|
—
|
|
Mortgage renewal fee
|
|
—
|
($18k)
|
$0
|
($35k)
|
—
|
—
|
—
|
|
Principal repaid - lease liability
|
|
—
|
$0
|
($3k)
|
($19k)
|
—
|
—
|
—
|
|
Proceeds from short-term loan
|
|
—
|
$0
|
$0
|
$300k
|
—
|
—
|
—
|
|
Proceeds from government loan
|
|
—
|
$60k
|
$0
|
$0
|
—
|
—
|
—
|
|
Cash (used in) provided by financing activities
|
|
—
|
$3.4m
|
$916k
|
($23k)
|
—
|
—
|
—
|
|
Cash, beginning of year
|
|
$2.4m
|
$2.4m
|
$1.1m
|
$745k
|
—
|
—
|
—
|
|
Listing expense
|
|
—
|
$0
|
$0
|
—
|
—
|
—
|
—
|
|
Marketable securities
|
|
—
|
$0
|
$0
|
—
|
—
|
—
|
—
|
|
Borrowing costs mortgage
|
|
—
|
($18k)
|
$0
|
—
|
—
|
—
|
—
|
|
Proceeds from issue of bonds, notes and debentures
|
|
—
|
$0
|
$0
|
—
|
—
|
—
|
—
|
|
Cash received from the reverse acquisition
|
|
—
|
$0
|
$0
|
—
|
—
|
—
|
—
|
|
Beginning Cash Position
|
|
—
|
—
|
—
|
$244.1m
|
$172.8m
|
$137.7m
|
$112.6m
|
|
Cash Flow From Continuing Financing Activities
|
|
—
|
—
|
—
|
($177.2m)
|
$32.3m
|
$44.6m
|
$118.8m
|
|
Cash Flow From Continuing Investing Activities
|
|
—
|
—
|
—
|
$52.6m
|
($69.1m)
|
($86.3m)
|
($145.0m)
|
|
Change In Other Current Assets
|
|
—
|
—
|
—
|
$9.9m
|
($42.8m)
|
($15.8m)
|
($57.0m)
|
|
Change In Payable
|
|
—
|
—
|
—
|
$3.4m
|
$13.1m
|
($1.7m)
|
($14.9m)
|
|
Change In Payables And Accrued Expense
|
|
—
|
—
|
—
|
$3.4m
|
$13.1m
|
($1.7m)
|
($14.9m)
|
|
Change In Working Capital
|
|
—
|
—
|
—
|
$13.3m
|
($29.7m)
|
($17.5m)
|
($71.9m)
|
|
Changes In Cash
|
|
—
|
—
|
—
|
($71.3m)
|
($35.1m)
|
($25.1m)
|
($1.0m)
|
|
End Cash Position
|
|
—
|
—
|
—
|
$172.8m
|
$137.7m
|
$112.6m
|
$111.6m
|
|
Financing Cash Flow
|
|
—
|
—
|
—
|
($177.2m)
|
$32.3m
|
$44.6m
|
$118.8m
|
|
Free Cash Flow
|
|
—
|
—
|
—
|
$35.7m
|
($67.4m)
|
($69.4m)
|
($26.1m)
|
|
Gain Loss On Investment Securities
|
|
—
|
—
|
—
|
$20.9m
|
$85.9m
|
$2.4m
|
$3.3m
|
|
Gain Loss On Sale Of Business
|
|
—
|
—
|
—
|
($20.1m)
|
($2.3m)
|
$0
|
—
|
|
Investing Cash Flow
|
|
—
|
—
|
—
|
$52.6m
|
($69.1m)
|
($86.3m)
|
($145.0m)
|
|
Issuance Of Capital Stock
|
|
—
|
—
|
$0
|
$0
|
—
|
—
|
—
|
|
Net Business Purchase And Sale
|
|
—
|
—
|
—
|
$42.7m
|
($125k)
|
($334k)
|
$0
|
|
Operating Gains Losses
|
|
—
|
—
|
—
|
($6.5m)
|
$79.1m
|
($6.5m)
|
($5.0m)
|
|
Other Non Cash Items
|
|
—
|
—
|
—
|
$2.3m
|
$1.2m
|
$1.9m
|
$6.5m
|
|
Proceeds From Stock Option Exercised
|
|
—
|
—
|
—
|
$0
|
($689k)
|
$6.4m
|
$9.1m
|
|
Purchase Of Business
|
|
—
|
—
|
—
|
($5.3m)
|
($125k)
|
($334k)
|
$0
|
|
Repurchase Of Capital Stock
|
|
—
|
—
|
$0
|
($395.0m)
|
—
|
—
|
—
|
|
Sale Of Business
|
|
—
|
—
|
$0
|
$48.0m
|
$0
|
$0
|
—
|
|
Unrealized Gain Loss On Investment Securities
|
|
—
|
—
|
$31.0m
|
$35.0m
|
$83.2m
|
—
|
—
|
|
Net cash provided by (used in) operating activities
|
|
—
|
($2.8m)
|
($1.1m)
|
$53.3m
|
$1.6m
|
$16.6m
|
$25.2m
|
|
Capital Expenditure Reported
|
|
—
|
—
|
—
|
($17.7m)
|
($69.0m)
|
($86.0m)
|
($51.3m)
|
|
Net Investment Properties Purchase And Sale
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
($93.7m)
|
|
Net Investment Purchase And Sale
|
|
—
|
—
|
$2.0m
|
$48.0m
|
—
|
—
|
—
|
|
Purchase Of Investment Properties
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
($93.7m)
|
|
Sale Of Investment
|
|
—
|
—
|
$2.0m
|
$48.0m
|
—
|
—
|
—
|
|
Other investing activities, net
|
|
—
|
—
|
—
|
$27.5m
|
$110k
|
$40k
|
$6k
|
|
Net Other Investing Changes
|
|
—
|
—
|
—
|
$27.5m
|
$110k
|
$40k
|
$6k
|
|
Net cash provided by (used in) investing activities
|
|
—
|
($1.8m)
|
($263k)
|
$52.6m
|
($69.1m)
|
($86.3m)
|
($145.0m)
|
|
Issuance Of Debt
|
|
—
|
—
|
—
|
$154.8m
|
$83.0m
|
$144.9m
|
$158.2m
|
|
Long Term Debt Issuance
|
|
—
|
—
|
—
|
$154.8m
|
$83.0m
|
$144.9m
|
$158.2m
|
|
Net Issuance Payments Of Debt
|
|
—
|
—
|
—
|
($154.9m)
|
$26.8m
|
$42.5m
|
$116.7m
|
|
Net Long Term Debt Issuance
|
|
—
|
—
|
—
|
($154.9m)
|
$26.8m
|
$42.5m
|
$116.7m
|
|
Repayments of debt
|
|
—
|
—
|
—
|
($309.6m)
|
($56.2m)
|
($102.4m)
|
($41.5m)
|
|
Long Term Debt Payments
|
|
—
|
—
|
—
|
($309.6m)
|
($56.2m)
|
($102.4m)
|
($41.5m)
|
|
Repayment Of Debt
|
|
—
|
—
|
—
|
($309.6m)
|
($56.2m)
|
($102.4m)
|
($41.5m)
|
|
Common Stock Issuance
|
|
—
|
—
|
$0
|
$0
|
—
|
—
|
—
|
|
Net Common Stock Issuance
|
|
—
|
—
|
$0
|
$0
|
—
|
—
|
—
|
|
Common Stock Payments
|
|
—
|
—
|
$0
|
($395.0m)
|
—
|
—
|
—
|
|
Contribution from noncontrolling interest
|
|
—
|
—
|
—
|
—
|
$12.0m
|
—
|
—
|
|
Cash Dividends Paid
|
|
—
|
—
|
$0
|
$0
|
—
|
—
|
—
|
|
Other financing activities, net
|
|
—
|
—
|
—
|
($8.5m)
|
($6.6m)
|
$2.1m
|
($6.9m)
|
|
Net Other Financing Charges
|
|
—
|
—
|
—
|
($22.4m)
|
$6.2m
|
($4.3m)
|
($6.9m)
|
|
Net cash provided by (used in) financing activities
|
|
—
|
$3.4m
|
$916k
|
($177.2m)
|
$32.3m
|
$44.6m
|
$118.8m
|
|
Effect Of Exchange Rate Changes
|
|
—
|
—
|
$0
|
$0
|
—
|
—
|
—
|
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
|
—
|
—
|
—
|
($71.3m)
|
($35.1m)
|
($25.1m)
|
($1.0m)
|
|
Net increase (decrease) in cash
|
|
—
|
($1.2m)
|
($401k)
|
$269k
|
—
|
—
|
—
|
|
Cash, cash equivalents and restricted cash at beginning of period
|
|
—
|
—
|
—
|
$172.8m
|
$137.7m
|
$112.6m
|
$111.6m
|
|
Change In Cash Supplemental As Reported
|
|
—
|
—
|
—
|
($71.3m)
|
($35.1m)
|
($25.1m)
|
($1.0m)
|
|
Net cash received (paid) for interest rate swaps
|
|
—
|
($197k)
|
($209k)
|
($1.2m)
|
$5.1m
|
$5.8m
|
$2.3m
|
|
Interest paid - mortgage
|
|
—
|
($197k)
|
($209k)
|
($265k)
|
$5.1m
|
$5.8m
|
$2.3m
|
|
Interest paid - lease liability
|
|
—
|
$0
|
($846)
|
($4k)
|
$5.1m
|
$5.8m
|
$2.3m
|
|
Taxes Refund Paid
|
|
—
|
—
|
$7.0m
|
$8.0m
|
—
|
—
|
—
|